Issuer Information

EDGAR: Contact Information
  • Name:
    NexPoint Life Sciences III DST
  • Address:
    300 CRESCENT COURT
    SUITE 700
    DALLAS, TEXAS 75201
  • Phone:
    (833) 697-6246
EDGAR: Other Information
  • Jurisdiction:
    DELAWARE
  • Entity Type:
    Other
  • Incorporated:
    Within 5 years (2023)
  • Previous Names:
    None

These are those Form D offerings for which this issuer is designated as the primary issuer.

EFDID/AccessionDetailsFed. ExemptionsNotices
508668: 0002008210-26-000001
First Sale: 2024-01-25
Security Type(s): Equity, Pooled Investment
Offer Amount: $30,661,253
Amount Sold: $25,178,789
Remaining: $5,482,464
06c, 3C, 3C.1, 3C.5

AZ, CA, CO, HI, IL, KS, MA, MD, ME, MN, NC, NM, NV, OK, OR, PA, SC, TX, WA, WI,

These Form D offerings are those which this issuer is defined as an issuer for the offering, but are not the primary issuer.

This issuer currently is not a non-primary issuer for any Form D offerings.